Loss of CADM1/TSLC1 Expression Is Associated with Poor Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma

Loss of CADM1/TSLC1 Expression Is Associated with Poor Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma

Aims. We sought to determine the relationship between CADM1/TSLC1 expression and clinicopathological characteristics in patients with esophageal squamous cell carcinoma (ESCC) and the correlation with survival. Materials and Methods. Two hundred and ninety-three ESCC tissues and paired adjacent norm...

Full description

Saved in:

Bibliographic Details
Main Authors:	De Zeng, Xiao Wu, Jin Zheng, Yixuan Zhuang, Jiongyu Chen, Chaoquan Hong, Fan Zhang, Mingyao Wu, Danxia Lin
Format:	Article
Language:	English
Published:	Wiley 2016-01-01
Series:	Gastroenterology Research and Practice
Online Access:	http://dx.doi.org/10.1155/2016/6947623
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CADM1/TSLC1 Identifies HTLV-1-Infected Cells and Determines Their Susceptibility to CTL-Mediated Lysis.
by: Kiruthika Manivannan, et al.
Published: (2016-04-01)

Human T-cell leukemia virus type 1 (HTLV-1) tax requires CADM1/TSLC1 for inactivation of the NF-κB inhibitor A20 and constitutive NF-κB signaling.
by: Rajeshree Pujari, et al.
Published: (2015-03-01)

High endothelin-converting enzyme-1 expression independently predicts poor survival of patients with esophageal squamous cell carcinoma
by: Ching-Fang Wu, et al.
Published: (2017-09-01)

Prognostic role and tumor-suppressive effects of CADM family members and the potential molecular mechanisms of CADM1 in neuroblastoma
by: Yu Wang, et al.
Published: (2025-05-01)

Increased coexpression of PD-L1 and TIM3/TIGIT is associated with poor overall survival of patients with esophageal squamous cell carcinoma
by: Qing Li, et al.
Published: (2021-10-01)

Clinical efficacy of different neoadjuvant therapies for resectable esophageal squamous cell carcinoma
by: Xiaoyang Wang, et al.
Published: (2025-06-01)

MST1 interactomes profiling across cell death in esophageal squamous cell carcinoma
by: Zhang Li, et al.
Published: (2024-12-01)

CCN1 promotes APRIL/BAFF signaling in esophageal squamous cell carcinoma but attenuates it in esophageal adenocarcinoma
by: Lingling Xing, et al.
Published: (2025-01-01)

Overexpressed PTOV1 associates with tumorigenesis and progression of esophageal squamous cell carcinoma
by: Rong Li, et al.
Published: (2017-06-01)

High NUSAP1 expression predicts poor survival in laryngeal squamous cell carcinoma
by: Shengkai Zhou, et al.
Published: (2025-04-01)

PINK1 suppresses malignant phenotypes in esophageal squamous cell carcinoma
by: Xiangyun Lu, et al.
Published: (2025-06-01)

Prognostic value of FCER1G expression and M2 macrophage infiltration in esophageal squamous cell carcinoma
by: Wei Peng, et al.
Published: (2025-02-01)

Prognostic prediction and diagnostic role of Rspondin 1 expression in esophageal squamous cell carcinoma
by: Xiaoxia Cheng, et al.
Published: (2025-01-01)

Expression and clinical significance of IGFBP7 and TGFβ1 in esophageal squamous cell carcinoma
by: REN Huaijing, MA Zhenqi WANG, Xuehong TAO Jianan
Published: (2025-01-01)

Detection of CADM1, MAL, and PAX1 Methylation by ddPCR for Triage of HPV-Positive Cervical Lesions
by: Maria Anisimova, et al.
Published: (2025-06-01)

Esophageal squamous cell carcinoma and prognosis in Taiwan
by: Ya‐Fu Cheng, et al.
Published: (2018-09-01)

The Expression and Prognostic Value of FGF2, FGFR3, and FGFBP1 in Esophageal Squamous Cell Carcinoma
by: Wenjing Zhang, et al.
Published: (2020-01-01)

Prognostic value of tumor‐infiltrating lymphocytes and PD‐L1 expression in esophageal squamous cell carcinoma
by: Jie Hu, et al.
Published: (2024-09-01)

Role of Oral and Esophageal Microbiota in Esophageal Squamous Cell Carcinoma
by: Kong Jinyu, et al.
Published: (2025-07-01)

Special AT-rich sequence binding protein 1 promotes tumor growth and metastasis of esophageal squamous cell carcinoma
by: Jun Ma, et al.
Published: (2017-03-01)

CADM1 controls actin cytoskeleton assembly and regulates extracellular matrix adhesion in human mast cells.
by: Elena P Moiseeva, et al.
Published: (2014-01-01)

ORF1p promotes proliferation and invasion of esophageal squamous cell carcinoma cells by regulating AJUBA expression
by: YANG Fan, et al.
Published: (2025-07-01)

Cutaneous metastasis in esophageal squamous cell carcinoma
by: Rajiv Baijal, et al.
Published: (2013-01-01)

Esophageal Papillomatosis Complicated by Squamous Cell Carcinoma
by: Tan Attila, et al.
Published: (2009-01-01)

Overexpression of cyclin‐dependent kinase 1 in esophageal squamous cell carcinoma and its clinical significance
by: Han‐Jie Zhang, et al.
Published: (2021-11-01)

Unraveling the power of radiomics: prediction and exploration of lymph node metastasis in stage T1/2 esophageal squamous cell carcinoma
by: Yu Zhang, et al.
Published: (2025-06-01)

Repression of CADM1 transcription by HPV type 18 is mediated by three-dimensional rearrangement of promoter-enhancer interactions.
by: Karen Campos-León, et al.
Published: (2025-01-01)

Cadm1 is a metastasis susceptibility gene that suppresses metastasis by modifying tumor interaction with the cell-mediated immunity.
by: Farhoud Faraji, et al.
Published: (2012-09-01)

miR-486 Promotes the Invasion and Cell Cycle Progression of Ovarian Cancer Cells by Targeting CADM1
by: Chenyang Li, et al.
Published: (2021-01-01)

Sirtuin1 (sirt1) regulates the glycolysis pathway and decreases cisplatin chemotherapeutic sensitivity to esophageal squamous cell carcinoma
by: Xuewen Yang, et al.
Published: (2024-12-01)

promoter methylation is associated with prognosis in esophageal squamous cell carcinoma
by: Xiaoying Chen, et al.
Published: (2017-02-01)

KDM1A epigenetically enhances RAD51 expression to suppress the STING-associated anti-tumor immunity in esophageal squamous cell carcinoma
by: Qingyuan Yang, et al.
Published: (2024-12-01)

The Mural Form of Eosinophilic Esophagitis Is Accompanied by Superficial Esophageal Squamous Cell Carcinoma
by: Zhao Jingsheng, et al.
Published: (2012-01-01)

Efficacy and safety of PD-1/PD-L1 inhibitors as first-line treatment for esophageal squamous cell carcinoma: a systematic review and meta-analysis
by: Wei Ren, et al.
Published: (2025-03-01)

SKA1/2/3 is a prognostic and predictive biomarker in esophageal adenocarcinoma and squamous cell carcinoma
by: Liming Zhang, et al.
Published: (2024-11-01)

Plasma CircCYP24A1 as a Novel Biomarker of Esophageal Squamous Cell Carcinoma
by: Ruolan Zhang M.M., et al.
Published: (2024-12-01)

Expression and correlation of Surfeit 4 gene in esophageal squamous cell carcinoma
by: Jun-xing Liu, et al.
Published: (2024-12-01)

Inhibition of Phosphoglycerate Kinase 1 Enhances Radiosensitivity of Esophageal Squamous Cell Carcinoma to X-rays and Carbon Ion Irradiation
by: Junru Chen, et al.
Published: (2025-05-01)

A comparative Analysis by SAGE of Gene Expression Profiles of Esophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma
by: Jantine W. P. M. van Baal, et al.
Published: (2008-01-01)

Corrigendum to “miR-486 Promotes the Invasion and Cell Cycle Progression of Ovarian Cancer Cells by Targeting CADM1”
by: Hao Wang, et al.
Published: (2021-01-01)